- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06103370
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage to HIV prevention and treatment services in Maryland. Study aims are to determine the effectiveness of a social network driven intervention to increase:
- HIV testing (primary);
- PrEP knowledge;
- Uptake of HIV services and pre-exposure prophylaxis (PrEP);
- Uptake of medication for opioid use disorder (MOUD) initiation.
Eligible participants who access syringe service programs (SSPs) serving two counties in Maryland and their risk network members (NMs) will be recruited using an established network inventory and coupon recruitment method. When an index successfully recruits NMs, the index-NM cluster will be randomized to either a peer-educator intervention arm or an equal-attention control arm. Index participants randomized to the peer-educator intervention arm will complete a training program adapted with stakeholder input to context that emphasizes effective communication, frequent HIV testing, and awareness of evidence-based HIV prevention and treatment services. An important innovation to the network intervention will be training indexes to use and distribute HIV self-test kits and naloxone to their NMs. Index participants randomized to the equal-attention control arm will receive training sessions focused on the opioid overdose epidemic and will not include any training to serve as a peer educator. All participants (indexes and NMs) will complete study assessments at baseline and at 3 and 9 months. We will compare the peer-educator intervention group and the equal-attention control group on rates of HIV testing, knowledge of PrEP options and resources, and rates of initiation of HIV treatment, PrEP, and MOUD treatment since the previous assessment (past 3 or 6 months).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Oluwaseun Falade-Nwulia, MBBS, MPH
- Phone Number: 410-550-6234
- Email: ofalade1@jhmi.edu
Study Contact Backup
- Name: Gregory Lucas, MD
- Phone Number: 410-614-0560
- Email: glucas@jhmi.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Inclusion criteria for index participants:
- Aged 18 or older
- Self-reported injection drug use in the prior month
- Accessed services at the SSP in the prior 3 months
- Willing to undergo training and attend weekly booster group sessions
- Able to recruit at least 1 drug use Network Member (NM) into study
- Willing to talk with peers about PWID topics such as HIV prevention and care
- Not previously enrolled in the study as index or NM
- English-speaking
Inclusion criteria for network member participants:
- Aged 18 or older
- Self-reported injection drug use in the prior month
- Have a valid coupon or able to recall the 3-digit ID number
- Not previously enrolled in the study as index or NM
- English-speaking
Exclusion criteria:
• Individuals lacking the capacity to consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Peer-educator-based network intervention
Indexes randomized to the intervention arm will complete a training program that emphasizes effective communication, frequent HIV testing, and awareness of evidence-based HIV prevention and treatment services.
An important innovation to the network intervention will be training indexes to use and distribute HIV self-test kits and naloxone to their network members (NMs).
|
The intervention is a social network-based method of dispersing HIV knowledge, HIV self-testing (HIVST) kits, and naloxone in social networks of people who inject drugs (PWID).
It targets index participants (peers) to receive training on HIVST, peer education, and linkage to syringe service programs (SSPs) for HIV services.
|
No Intervention: Equal-attention control
This group will receive training sessions that will be focused on the opioid overdose epidemic and will not include any training to serve as a peer educator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of HIV testing for Network Members
Time Frame: 3 months, 9-months
|
Proportion of Network Members (both study arms) who report that they conducted HIV testing since the previous study assessment (i.e., in the prior 3 or 6 months).
|
3 months, 9-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of HIV testing for Index and Network Members
Time Frame: 3- and 9-month follow-up
|
Proportion of Index and Network Members (both study arms) who report testing since the previous study assessment (i.e., in the prior 3 or 6 months).
|
3- and 9-month follow-up
|
Proportion of HIV testing for Index Members
Time Frame: 3- and 9-month follow-up
|
Proportion of Index Members (both study arms) who report testing since the previous study assessment (i.e., in the prior 3 or 6 months).
|
3- and 9-month follow-up
|
Proportion of HIV negative participants who have used PrEP uptake
Time Frame: 3- and 9-month follow-up
|
Proportion of HIV-negative participants who have used PrEP (yes/no) since the previous study assessment (i.e., in the prior 3 or 6 months) among Network Members.
|
3- and 9-month follow-up
|
Change in Knowledge of PrEP options
Time Frame: 3- and 9-month follow-up
|
Knowledge of PrEP options and resources measured by questionnaire at 3 and 9 months among Network Members.
|
3- and 9-month follow-up
|
Proportion of participants using anti-retroviral therapy (ART)
Time Frame: 3- and 9-month follow-up
|
Proportion of participants living with HIV who reported they are currently using anti-retroviral therapy (ART), (yes/no) at the 3- or 9-month follow-up among Network Members.
|
3- and 9-month follow-up
|
Proportion of participants who have used Medication for opioid use disorder (MOUD) uptake
Time Frame: 3- and 9-month follow-up
|
Proportion of participants who report that they have used MOUD (yes/no) since the previous study assessment (i.e., in the prior 3 or 6 months) among Network Members.
|
3- and 9-month follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Oluwaseun Falade-Nwulia, MBBS, MPH, Johns Hopkins School of Medicine
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00374291
- R01DA058387 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Peer-educator-based network
-
Medical College of WisconsinNational Institute on Drug Abuse (NIDA)CompletedSexually Transmitted Diseases | HIVEl Salvador
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
The University of Tennessee, KnoxvilleColorado State UniversityActive, not recruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
University of PennsylvaniaPfizer; Robert Wood Johnson FoundationCompletedCardiovascular Diseases | Blood PressureUnited States
-
University of PittsburghPenn State UniversityCompleted
-
Lighthouse TrustUniversity of North Carolina, Chapel Hill; World Health Organization; Kamuzu... and other collaboratorsUnknown
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
University of PennsylvaniaLyft, Inc.CompletedPrimary Health Care | Social Determinants of Health | Transportation | Appointments and SchedulesUnited States
-
University College, LondonLondon School of Hygiene and Tropical Medicine; Africa Health Research InstituteUnknown
-
The University of Hong KongCompleted